Literature DB >> 6548005

The management of ophthalmic Graves' disease.

C R Leone.   

Abstract

From a series of 124 consecutive patients, parameters were developed in the management of Graves' disease. Patients who were stable with symptomatic treatment were observed and followed. Oral steroids, 40 to 80 mg prednisone daily, were moderately effective in reducing progressive soft tissue inflammatory signs, but were less effective in controlling myopathy and lid retraction. Radiotherapy, 1000 rad from each lateral port, was most effective in halting the progressive inflammatory component, particularly in those who had a recent rapid rate of change. Dysthyroid optic neuropathy required high dose steroids; if it was not effective, decompression of the orbit was carried out. Once the disease became stable, myopathy, lid retraction, and exophthalmos were surgically treated on an elective basis. The techniques utilized were tarsorrhaphy, lateral canthoplasty, upper and lower eyelid retractor release, and one- to three-wall orbital decompression.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548005     DOI: 10.1016/s0161-6420(84)34221-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  9 in total

1.  Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.

Authors:  Gennaro Ambrosio; Giuseppe Ferrara; Raffaella Vitale; Rocco De Marco
Journal:  Doc Ophthalmol       Date:  2003-03       Impact factor: 2.379

2.  Thyroid eye disease. More treatment options.

Authors:  A N Harnett; A MacDonald; G N Dutton
Journal:  BMJ       Date:  1993-05-01

3.  A role for methotrexate in the management of non-infectious orbital inflammatory disease.

Authors:  J R Smith; J T Rosenbaum
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

4.  Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone.

Authors:  R Ebner; M H Devoto; D Weil; M Bordaberry; C Mir; H Martinez; L Bonelli; H Niepomniszcze
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

5.  The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.

Authors:  G B Bartley
Journal:  Trans Am Ophthalmol Soc       Date:  1994

6.  Staged Treatment of Asymmetrical Age-related Changes in the Eyelid and Thyroid Eye Disease.

Authors:  Tokuei Takahira; Shinsuke Akita; Haruka Maei; Yoshitaka Kubota; Nobuyuki Mitsukawa
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-07-21

7.  Changes in Eyelid Parameters after Orbital Decompression according to the Surgical Approach in Thyroid Eye Disease.

Authors:  Seong Ho Kim; Sung Mo Kang
Journal:  Korean J Ophthalmol       Date:  2021-09-06

8.  Low- vs. high-dose radiotherapy in Graves' ophthalmopathy: a retrospective comparison of long-term results.

Authors:  Thomas Weissmann; Sebastian Lettmaier; Anna-Jasmina Donaubauer; Christoph Bert; Manfred Schmidt; Friedrich Kruse; Oliver Ott; Markus Hecht; Rainer Fietkau; Benjamin Frey; Florian Putz
Journal:  Strahlenther Onkol       Date:  2021-04-16       Impact factor: 4.033

9.  Change in eyelid parameters after orbital decompression in thyroid-associated orbitopathy.

Authors:  Hong Hyun Park; Yeoun Sook Chun; Nam Ju Moon; Jee Taek Kim; Sang Joon Park; Jeong Kyu Lee
Journal:  Eye (Lond)       Date:  2018-02-02       Impact factor: 3.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.